Clinical Trials Directory

Trials / Completed

CompletedNCT03637829

Effect of Morning Snack on Cognitive Performance in Adults

Effect of Mid-morning Snacks on Cognitive Performance, Satiety, Food Intake, and Glycemic Response in Normal Weight Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Toronto Metropolitan University · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

To characterize the effects of three chocolate snacks on cognitive performance, subjective appetite, food intake control, and glycemic response in normal weight adults.

Detailed description

On 4 separate mornings, 7 days apart, 12 hours after an overnight fast, and 3 hours after a standardized breakfast of a cereal bar, orange juice and fruit cup, participants will consume isocaloric snacks of white chocolate, 2 types of dark chocolate or control (water), followed by an ad libitum pizza lunch 90 minutes later. Upon arrival, at baseline (0 minutes), participants will be asked to complete the motivation-to-eat, global vigor and subjective emotion visual analogue scales (VAS), a battery of cognitive performance tasks and have blood samples taken, as reported and validated in our previous studies. Over the 90 minute testing period, blood samples will be taken,the VAS questions will be completed and cognitive tasks will be completed. Cognitive performance assessments will include learning and memory, spatial memory, attention and processing speed, and executive functions. VAS measuring physical comfort is completed pre- and post-meal. Ad libitum food intake from a test meal will be measured.

Conditions

Interventions

TypeNameDescription
OTHERControlWater
OTHERWhite chocolateExperimental snack treatment
OTHERDark chocolate 1Experimental snack treatment
OTHERDark chocolate 2Experimental snack treatment

Timeline

Start date
2018-03-05
Primary completion
2018-09-01
Completion
2018-09-01
First posted
2018-08-20
Last updated
2019-05-21

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03637829. Inclusion in this directory is not an endorsement.